MDMA Use by Paris Medical Students: Prevalence and Characteristics
Balthazar Bazin, David Duroy, Michel Lejoyeux
Substance Use & Misuse October 24, 2020 DOI: 10.1080/10826084.2020.1837167 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional study Peer reviewed |
|---|---|
| Sample size | 592 |
| Population | Paris VII medical students |
| Topics | Addiction Cannabis MDMA |
| Citations | 27 |
| Key findings | 21.5% of French medical students had experimented with MDMA, and its use was associated with male sex, tobacco and cannabis use, other illicit drug use, and frequent alcohol consumption. |
Abstract
3,4-Methylenedioxy-N-methylamphetamine (MDMA) is increasing being used by youth in Europe and in France, but characteristics of its use are unknown.
Objectives: The aim was to characterize MDMA use in a sample of French medical students.
Methods: Cross-sectional study of Paris VII medical students (N = 592) with an online self-reporting questionnaire.
Results: 592 students completed the online questionnaire. 21.5% (n = 127) had experimented with MDMA. Use of MDMA was associated with male sex (p p p p p p
Conclusions: Other studies focusing on drug consumption among students are necessary to define specific public health strategies of prevention and harmful reduction.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
MDMA use was associated with male sex, tobacco and cannabis use, other illicit drug use and frequent alcohol consumption.
Synthesized
Comparable studies
Other cross-sectional and survey studies on MDMA for addiction, most cited first.
Citations in the library
Cited by 2
- Review of Selected 2-Phenylethylamine Derivatives and Opioids, Systematic Review of Their Effects on Psychomotor Abilities and Driving Performance: Psychopharmacology in the Context of Road Safety Pharmaceuticals October 28, 2025
- Risk for Ecstasy Use Disorder and Other Substance Use Among International Users of Recreational Ecstasy/Molly/MDMA. Journal of Psychoactive Drugs 2024
Cites 14
- 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry May 1, 2018
- Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology November 1, 2018
- Self-reported use of novel psychoactive substances among attendees of electronic dance music venues. The American Journal of Drug and Alcohol Abuse November 1, 2016
- Cortisol and 3,4-Methylenedioxymethamphetamine: Neurohormonal Aspects of Bioenergetic Stress in Ecstasy Users Neuropsychobiology 2009
- How MDMA's Pharmacology and Pharmacokinetics Drive Desired Effects and Harms The Journal of Clinical Pharmacology January 16, 2014
and 9 more in the library